Notably, the RhoA/Rho-kinase (ROCK) pathway can be activated by ET-1 to promote myofibroblast differentiation and ECM accumulation in the dermis, thereby markedly participating in the pathophysiology of abnormal scar/keloid formation. Here, EDN1 is linked to keloid.